Previously, several studies based on primarily Caucasian and some Asian datasets have suggested association of PNPLA3 risk variant with increased severity of hepatic fibrosis and cirrhosis [30, 31] and enhanced progression of liver fibrosis or cirrhosis [29] or independent steatosis [10, 32] in CHC settings. Here, PNPLA3 is linked to steatosis.